Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × ivosidenib × Other hematologic neoplasm × Clear all

Status

Sponsor Class

Study Type

Interventional 22 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Flow Cytometry 31 Gene Expression Profiling 30 Surveys and Questionnaires 22 Polymerase Chain Reaction 20 Microarray Analysis 20 Blood Specimen Collection 16 Interviews as Topic 15 Amplified Fragment Length Polymorphism Analysis 13 Reverse Transcriptase Polymerase Chain Reaction 12 Cytogenetic Analysis 12 venetoclax 11 Imatinib Mesylate 11 Rituximab 10 Dasatinib 10 Immunologic Techniques 9 DNA Methylation 9 Blotting, Western 9 Psychiatric Rehabilitation 8 Azacitidine 8 nilotinib 7 ibrutinib 7 Watchful Waiting 7 Therapeutics 7 Specimen Handling 7 In Situ Hybridization, Fluorescence 7 Base Sequence 7 ponatinib 6 bosutinib 6 Data Collection 6 fludarabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06181734 2026-02-10

CONFIDHENCE

iOMEDICO AG

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡